Investors Asset Management Of Georgia Inc Xilio Therapeutics, Inc. Transaction History
Investors Asset Management Of Georgia Inc
- $194 Million
- Q1 2025
A detailed history of Investors Asset Management Of Georgia Inc transactions in Xilio Therapeutics, Inc. stock. As of the latest transaction made, Investors Asset Management Of Georgia Inc holds 10,000 shares of XLO stock, worth $7,800. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$7,800% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding XLO
# of Institutions
37Shares Held
14MCall Options Held
0Put Options Held
0-
Bain Capital Life Sciences Investors, LLC Boston, MA4.57MShares$3.56 Million1.18% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD3MShares$2.34 Million0.12% of portfolio
-
River Vest Venture Management LLC St. Louis, MO1.44MShares$1.12 Million16.6% of portfolio
-
Morgan Stanley New York, NY1MShares$781,0600.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA903KShares$703,9740.0% of portfolio
About Xilio Therapeutics, Inc.
- Ticker XLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,471,600
- Market Cap $21.4M
- Description
- Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine prog...